Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
2013 Standout
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
2013 Standout
Lifestyle Interventions for Patients With and at Risk for Type 2 Diabetes
2013
The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis
2017
Efficacy of a Community-Based Physical Activity Program KM2H2 for Stroke and Heart Attack Prevention among Senior Hypertensive Patients: A Cluster Randomized Controlled Phase-II Trial
2015
Modulation of oxidative stress as an anticancer strategy
2013 Standout
The influence of 4‐hydroxy‐2‐nonenal on proliferation, differentiation and apoptosis of human osteosarcoma cells
2005
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
2015 Standout
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
2017 Standout
4-Hydroxynonenal as a bioactive marker of pathophysiological processes
2003
Uncomplicated Urinary Tract Infection
2012 Standout
Type 2 diabetes mellitus
2015 Standout
Exercise-based cardiac rehabilitation for coronary heart disease
2011 Standout
Drug Treatment for Obesity in the Post-Sibutramine Era
2011
The global epidemiology of hypertension
2020 Standout
European Guidelines for Obesity Management in Adults
2015 Standout
Pharmaceutical and therapeutic Potentials of essential oils and their individual volatile constituents: a review
2007 Standout
Salt consumption and cardiovascular, renal, and hypertensive diseases
2011
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Trends in Obesity Among Adults in the United States, 2005 to 2014
2016 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
The "Two-Faced" Effects of Reactive Oxygen Species and the Lipid Peroxidation Product 4-Hydroxynonenal in the Hallmarks of Cancer
2010
Lifestyle Interventions for Patients With and at Risk for Type 2 Diabetes
2013
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
2013 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Pesticides and oxidative stress: a review.
2004 Standout
International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
2011 Standout
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
2016
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies
2021 Standout
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
Treatment of Obesity in Mitigating Metabolic Risk
2020
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association
2016 Standout
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Lipid Peroxidation-Derived Aldehydes, 4-Hydroxynonenal and Malondialdehyde in Aging-Related Disorders
2018
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Efficacy and safety of lorcaserin in obese adults: a meta‐analysis of 1‐year randomized controlled trials (RCTs ) and narrative review on short‐termRCTs
2013
Oxidative Stress and Lipid Peroxidation Products in Cancer Progression and Therapy
2012
Works of Thomas Semlitsch being referenced
Benefit assessment of salt reduction in patients with hypertension: systematic overview
2011
Evaluating Guidelines
2015
Long-term effects of weight-reducing diets in hypertensive patients
2011
Long-term effects of weight-reducing drugs in hypertensive patients
2013
Clinical effectiveness of stress-reduction techniques in patients with hypertension
2014
Increasing Physical Activity for the Treatment of Hypertension: A Systematic Review and Meta-Analysis
2013
Long-term effects of weight-reducing diets in people with hypertension
2016
Differential influence of the lipid peroxidation product 4-hydroxynonenal on the growth of human lymphatic leukaemia cells and human periopherial blood lymphocytes.
2002